Home > Insider Trading > Filing (0001140361-15-028591)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
946486	Discovery Laboratories Inc	DSCO	Biological Products, (No Disgnostic Substances) (2836)	943171943

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1624401	Steven Simonson	2600 Kelly Road Suite 100 Warrington PA 18976	Svp, Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-07-22	16,667	$0.00	16,687	No	4	P	Direct
Common Stock	Acquisiton	2015-03-31	2,836	$1.19	8,168	No	5	A	Indirect	By Trust
Common Stock	Acquisiton	2015-06-30	4,964	$0.68	13,132	No	5	A	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	5	A	Indirect	By Trust
No	5	A	Indirect	By Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Warrants (Right to Buy)	Acquisiton	2015-07-22	16,667	$0.00	16,667	$0.70

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,667	2015-07-22	2022-07-22	No	4	P	Direct

Footnotes

Common Stock in connection with the purchase of Series A units acquired in an underwritten public offering of Series A units and Series B units with a unit purchase price of $0.60. Each Series A unit consists of one share of common stock and one Series A warrant to purchase one share of common stock at an initial exercise price of $0.70 per share. Refer to Table II for related Series A warrant information.
Transaction reported on Table I represents Issuer's matching stock contribution pursuant to 401(k) plan.
Series A Warrants in connection with the purchase of Series A units acquired in an underwritten public offering of Series A units and Series B units with a unit purchase price of $0.60. Each Series A unit consists of one share of common stock and one Series A warrant to purchase one share of common stock at an initial exercise price of $0.70 per share. Refer to Table I for related common stock information.